- Home
- ADCT vs HBB Comparison
ADCT vs HBB Comparison
Compare ADCT & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- HBB
- Stock Information
- Founded
- ADCT 2011
- HBB 1904
- Country
- ADCT Switzerland
- HBB United States
- Employees
- ADCT N/A
- HBB N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- HBB Home Furnishings
- Sector
- ADCT Health Care
- HBB Consumer Discretionary
- Exchange
- ADCT Nasdaq
- HBB Nasdaq
- Market Cap
- ADCT 241.0M
- HBB 242.8M
- IPO Year
- ADCT 2020
- HBB 2017
- Fundamental
- Price
- ADCT $2.78
- HBB $16.83
- Analyst Decision
- ADCT Strong Buy
- HBB
- Analyst Count
- ADCT 6
- HBB 0
- Target Price
- ADCT $7.80
- HBB N/A
- AVG Volume (30 Days)
- ADCT 937.9K
- HBB 24.8K
- Earning Date
- ADCT 08-05-2025
- HBB 07-30-2025
- Dividend Yield
- ADCT N/A
- HBB 2.85%
- EPS Growth
- ADCT N/A
- HBB 18.18
- EPS
- ADCT N/A
- HBB 2.43
- Revenue
- ADCT $75,817,000.00
- HBB $659,788,000.00
- Revenue This Year
- ADCT $10.65
- HBB N/A
- Revenue Next Year
- ADCT $15.05
- HBB N/A
- P/E Ratio
- ADCT N/A
- HBB $6.93
- Revenue Growth
- ADCT 10.49
- HBB 5.46
- 52 Week Low
- ADCT $1.05
- HBB $13.25
- 52 Week High
- ADCT $4.13
- HBB $31.78
- Technical
- Relative Strength Index (RSI)
- ADCT 47.62
- HBB 40.71
- Support Level
- ADCT $3.21
- HBB $16.58
- Resistance Level
- ADCT $3.97
- HBB $17.60
- Average True Range (ATR)
- ADCT 0.38
- HBB 0.80
- MACD
- ADCT -0.12
- HBB -0.19
- Stochastic Oscillator
- ADCT 3.43
- HBB 11.52
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.